-
Particle Sciences Acquired by Lubrizol
The Lubrizol Corporation announced that it has acquired Bethlehem-based Particle Sciences, a global leader in complex formulations including drug eluting device product development as well as sterile and particulate drug products. Lubrizol has approximately 9,000 employees worldwide and 2014 revenues of $7 billion. The acquisition further expands Lubrizol LifeSciences’ pharmaceutical development capabilities. Particle Sciences will retain Continue Reading…
-
Cernostics Paper Published in Journal of Pathology Informatics
Cernostics’ paper describes a biomarker imaging approach, TissueCypher™, that quantifies key components of biopsies such as those found in cancer and pre-cancer conditions. Read more: http://bit.ly/1K6FXIi